Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bujanova, S. Parakh, A. Guhan (Middlesbrough, United Kingdom). Incidence of venous thromboembolism 8-weeks post discharge in hospitalised medical patients not receiving thrombo-prophylaxis. Eur Respir J 2008; 32: Suppl. 52, 1061

Member's Comments

No comment yet.

Related content which might interest you: Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Sticker reminders improve VTE prophylaxis appropriatness in hospitalized patients Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism Source: Eur Respir J 2013; 41: 588-592 Year: 2013 Early discharge and outpatient treatment of patients admitted for acute pulmonary embolism Source: Eur Respir J 2013; 41: 486-487 Year: 2013 Early discharge and outpatient treatment of patients admitted for acute pulmonary embolism Source: Eur Respir J 2013; 41: 487-488 Year: 2013 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients Source: Eur Respir J 2004; 24: Suppl. 48, 273s Year: 2004 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Incidence of thromboembolic events during first 10 days hospitalization in male pulmonary diseases ward Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Primary prophylaxis against venous thromboembolism in medical in-patients: audit of our practice in a large teaching hospital Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006 Prevalence and incidence of deep venous thrombosis among patients in intensive care unit Source: Eur Respir J 2007; 30: Suppl. 51, 82s Year: 2007 Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review Source: Eur Respir J 2009; 33: 1148-1155 Year: 2009 Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment Source: Eur Respir J, 58 (2) 2101033; 10.1183/13993003.01033-2021 Year: 2021 Prevalence and characteristics of venous thromboembolism in severe exacerbation of COPD in a tertiary care hospital in India Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? Source: Eur Respir J, 55 (1) 1902323; 10.1183/13993003.02323-2019 Year: 2020 Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? Source: Eur Respir J, 55 (1) 1902028; 10.1183/13993003.02028-2019 Year: 2020 Early discharge of patients with pulmonary embolism: feasibility of domicillary anticoagulation Source: Eur Respir J 2003; 22: Suppl. 45, 219s Year: 2003 Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015